Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1984 1
1985 1
1987 1
1992 1
1994 1
1995 1
1996 1
1997 7
1998 1
1999 2
2001 2
2002 3
2003 1
2004 1
2005 1
2006 3
2007 4
2008 4
2009 9
2010 1
2011 4
2012 3
2013 6
2014 4
2015 3
2016 9
2017 5
2018 5
2019 6
2020 6
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors.
Moores SL, Chiu ML, Bushey BS, Chevalier K, Luistro L, Dorn K, Brezski RJ, Haytko P, Kelly T, Wu SJ, Martin PL, Neijssen J, Parren PW, Schuurman J, Attar RM, Laquerre S, Lorenzi MV, Anderson GM. Moores SL, et al. Among authors: schuurman j. Cancer Res. 2016 Jul 1;76(13):3942-53. doi: 10.1158/0008-5472.CAN-15-2833. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216193 Free article.
Complement is activated by IgG hexamers assembled at the cell surface.
Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, Voorhorst M, Ugurlar D, Rosati S, Heck AJ, van de Winkel JG, Wilson IA, Koster AJ, Taylor RP, Saphire EO, Burton DR, Schuurman J, Gros P, Parren PW. Diebolder CA, et al. Among authors: schuurman j. Science. 2014 Mar 14;343(6176):1260-3. doi: 10.1126/science.1248943. Science. 2014. PMID: 24626930 Free PMC article.
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing.
Engelberts PJ, Hiemstra IH, de Jong B, Schuurhuis DH, Meesters J, Beltran Hernandez I, Oostindie SC, Neijssen J, van den Brink EN, Horbach GJ, Verploegen S, Labrijn AF, Salcedo T, Schuurman J, Parren PWHI, Breij ECW. Engelberts PJ, et al. Among authors: schuurman j. EBioMedicine. 2020 Feb;52:102625. doi: 10.1016/j.ebiom.2019.102625. Epub 2020 Jan 23. EBioMedicine. 2020. PMID: 31981978 Free PMC article.
Opening the door to innovation.
Schuurman J, Graus YF, Labrijn AF, Ruuls S, Parren PW. Schuurman J, et al. MAbs. 2014 Jul-Aug;6(4):812-9. doi: 10.4161/mabs.29004. Epub 2014 Apr 24. MAbs. 2014. PMID: 24784437 Free PMC article. Review.
Mind the gap.
Schuurman J, W H I Parren P. Schuurman J, et al. Methods. 2014 Jan 1;65(1):1-4. doi: 10.1016/j.ymeth.2013.10.012. Epub 2013 Oct 30. Methods. 2014. PMID: 24184353 No abstract available.
IgG4 breaking the rules.
Aalberse RC, Schuurman J. Aalberse RC, et al. Among authors: schuurman j. Immunology. 2002 Jan;105(1):9-19. doi: 10.1046/j.0019-2805.2001.01341.x. Immunology. 2002. PMID: 11849310 Free PMC article. Review.
Immunoglobulin G4: an odd antibody.
Aalberse RC, Stapel SO, Schuurman J, Rispens T. Aalberse RC, et al. Among authors: schuurman j. Clin Exp Allergy. 2009 Apr;39(4):469-77. doi: 10.1111/j.1365-2222.2009.03207.x. Epub 2009 Feb 13. Clin Exp Allergy. 2009. PMID: 19222496 Review.
When binding is enough: nonactivating antibody formats.
Labrijn AF, Aalberse RC, Schuurman J. Labrijn AF, et al. Among authors: schuurman j. Curr Opin Immunol. 2008 Aug;20(4):479-85. doi: 10.1016/j.coi.2008.05.010. Epub 2008 Jul 9. Curr Opin Immunol. 2008. PMID: 18577454 Review.
98 results